Kiniksa Pharmaceuticals International, plc Non Peo Neo Avg Total Comp Amt
Kiniksa Pharmaceuticals International, plc (KNSA) reported Non Peo Neo Avg Total Comp Amt of $3.51 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-16.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-04-16
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $3.51M DEF 14A · filed 2026-04-16 |
| 2024-12-31 | $2.37M DEF 14A · filed 2026-04-16 |
| 2023-12-31 | $1.77M DEF 14A · filed 2026-04-16 |
| 2022-12-31 | $1.92M DEF 14A · filed 2026-04-16 |
| 2021-12-31 | $1.70M DEF 14A · filed 2026-04-16 |